ALT Altimmune, Inc. - Common Stock
ALT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
ALT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
ALT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
- Beli Kuat 4 26,7%
- Beli 9 60,0%
- Tahan 2 13,3%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
9 analis · 2026-08-19Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.12 | $-0.14 | 0.02% |
| 31 Maret 2026 | $-0.18 | $-0.25 | 0.07% |
| 31 Des. 2025 | $-0.27 | $-0.25 | -0.02% |
| 30 Sep. 2025 | $-0.21 | $-0.28 | 0.07% |
| 30 Juni 2025 | $-0.27 | $-0.33 | 0.06% |
| 31 Maret 2025 | $-0.26 | $-0.37 | 0.11% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| EIKN | — | — | — | — | — | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| R&D Expense | $66M | $82M | $66M | $71M | $75M | $50M | $18M | $18M | $18M | $7M | $5M | $9M | |
| SG&A Expense | $28M | $21M | $18M | $17M | $15M | $13M | $9M | $10M | $8M | $7M | $6M | $11M | |
| Operating Expenses | $95M | $103M | $96M | $88M | $101M | $63M | $27M | $53M | $63M | $14M | $14M | $20M | |
| Operating Income | $-94M | $-103M | $-96M | $-88M | $-97M | $-55M | $-21M | $-43M | $-52M | $-11M | $-3M | $-10M | |
| Interest Expense | · | · | $35.0K | $8.0K | $5.0K | $9.4K | $2.2K | $297.1K | $162.1K | $38.5K | $54.6K | $210.4K | |
| Interest Income | $8M | $8M | $7M | $3M | $203.0K | $322.5K | $843.4K | $226.6K | $47.6K | $1.0K | · | · | |
| Other Non-op | $-190.0K | $48.0K | $166.0K | $-32.0K | $-374.0K | $24.1K | $15.1K | $277.9K | $5.7K | $42.3K | $8.1K | $-762 | |
| Pretax Income | $-89M | $-95M | $-88M | $-85M | $-97M | $-54M | $-21M | $-45M | $-52M | $-11M | $-3M | $-10M | |
| Income Tax | $-681.0K | · | · | $-197.0K | · | $-5M | $-58.5K | $-6M | $-6M | $0 | $61.7K | $61.7K | |
| Net Income | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| EPS (Basic) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.97 | $-0.05 | $-0.17 | |
| EPS (Diluted) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.95 | $-0.05 | $-0.17 | |
| Shares (Basic) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,306,962 | 63,986,013 | 57,535,325 | |
| Shares (Diluted) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,657,802 | 63,986,013 | 57,535,325 | |
| EBITDA | $-94M | $-103M | $-96M | $-88M | $-96M | $-55M | $-21M | $-43M | · | $-11M | $-3M | $-10M |
Neraca 29
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $37M | $135M | $111M | $190M | $116M | $9M | $34M | $9M | $3M | $16M | $19M | |
| Short-term Investments | $230M | $95M | $63M | $74M | · | $100M | $28M | · | · | $67M | $0 | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $400.0K | |
| Prepaid Expense | $3M | $2M | $7M | $5M | $8M | $2M | $470.2K | $548.1K | $994.3K | $420.4K | $181.7K | $199.2K | |
| Current Assets | $278M | $137M | $210M | $193M | $204M | $230M | $39M | $39M | $23M | $4M | $17M | $19M | |
| PP&E (Net) | $312.0K | $413.0K | $651.0K | $1M | $1M | $1M | $1M | $1M | $603.1K | $177.9K | $233.7K | $325.8K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $3M | |
| Accum. Depreciation | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $951.8K | $905.3K | $2M | $2M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | · | $19M | $22M | $2M | |
| Intangibles | · | $0 | $0 | $12M | $12M | $13M | $13M | $14M | $39M | $15M | · | · | |
| Other Non-current Assets | $1M | $2M | $363.0K | $615.0K | $872.0K | $977.2K | $128.5K | $183.7K | $238.9K | $22.2K | $53.4K | $53.4K | |
| Total Assets | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Accounts Payable | $3M | $211.0K | $2M | $5M | $2M | $612.3K | $18.2K | $372.9K | $129.1K | $2M | $521.1K | $391.4K | |
| Accrued Liabilities | · | · | · | · | · | $11M | $4M | $4M | $4M | $3M | · | · | |
| Short-term Debt | · | · | · | · | · | · | · | $71.6K | $49.7K | $458.6K | · | · | |
| Current Liabilities | $15M | $10M | $12M | $17M | $18M | $12M | $4M | $5M | $4M | $5M | $2M | $3M | |
| Capital Leases | $1M | $1M | $175.0K | $672.0K | $1M | $1M | $1M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $58.5K | $6M | $442.6K | $380.8K | $319.0K | |
| Other Non-current Liabilities | $6M | $5M | $40.0K | $60.0K | $80.0K | $110.3K | $130.2K | $140.1K | $160.0K | $442.6K | $433.4K | $493.1K | |
| Total Liabilities | $55M | $16M | $17M | $22M | $20M | $19M | $9M | $6M | $14M | $6M | $3M | $4M | |
| Long-term Debt | $34M | · | · | · | · | · | · | $500.0K | $500.0K | $526.0K | · | · | |
| Total Debt | $34M | · | · | $5M | $1M | $2M | $2M | $71.6K | · | · | $0 | $746.1K | |
| Common Stock | $11.0K | $7.0K | $7.0K | $5.0K | $4.0K | $3.7K | $1.5K | $876 | $61 | $692 | $6.4K | $6.4K | |
| Paid-in Capital | $879M | $690M | $665M | $568M | $497M | $417M | $188M | $170M | $122M | $71M | $240M | $239M | |
| Retained Earnings | $-649M | $-561M | $-466M | $-378M | $-293M | $-186M | $-137M | $-117M | $-78M | $-31M | $-224M | $-220M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $0 | $-229.5K | |
| Stockholders' Equity | $225M | $124M | $194M | $185M | $199M | $226M | $46M | $48M | $39M | $32M | $43M | $18M | |
| Liabilities + Equity | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Shares Outstanding | 110,882,735 | 72,352,701 | 70,677,400 | 49,199,845 | 40,993,768 | 37,142,946 | 15,312,167 | 9,078,238 | 608,499 | 6,917,204 | 64,382,086 | 63,603,303 |
Arus Kas 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $-205.0K | $551.0K | $428.9K | $387.3K | · | · | · | · | · | |
| Stock-based Comp | $16M | $14M | $11M | $8M | $6M | $3M | $1M | $773.2K | $1M | $965.4K | $613.0K | $2M | |
| Deferred Tax | $-681.0K | · | · | · | · | · | $-58.5K | $-6M | $-3M | $61.8K | $61.7K | $61.7K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $3M | $0 | |
| Other Non-cash | · | · | · | $14M | $13M | $12M | · | · | · | · | · | · | |
| Operating Cash Flow | $-68M | $-80M | $-76M | $-63M | $-78M | $-34M | $-10M | $-9M | $-20M | $-6M | $-3M | $-8M | |
| CapEx | $11.0K | · | $47.0K | $126.0K | $12M | $204.0K | $1.2K | $975.4K | $112.4K | $125.0K | $86.5K | $92.3K | |
| Investing Cash Flow | $-132M | $-28M | $14M | $-73M | $88M | $-72M | $-28M | $-1M | $14M | · | · | · | |
| Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Net Stock Activity | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Financing Cash Flow | $207M | $10M | $86M | $57M | $65M | $213M | $13M | $32M | $16M | · | · | · | |
| Net Change in Cash | $7M | $-98M | $24M | $-79M | $74M | $107M | $-25M | $22M | $9M | $138M | $-3M | $8M | |
| Free Cash Flow | $-68M | · | $-76M | $-63M | $-90M | $-35M | $-10M | $-10M | · | $201M | $-3M | $-9M | |
| Levered FCF | · | · | · | $-63M | · | $-35M | $-10M | $-11M | · | · | $-3M | $-9M |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% | -669.5% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| Net Margin | -214861.0% | -475295.0% | -20762.2% | 124577.9% | -2201.4% | -599.2% | -353.7% | -379.2% | · | 115286.4% | · | · | |
| Pretax Margin | -216522.0% | -475295.0% | -20762.2% | 124867.7% | -2201.4% | -665.4% | -354.7% | -438.7% | · | 121929.0% | · | · | |
| EBITDA Margin | -230461.0% | -515860.0% | -22518.5% | 129330.9% | -2184.9% | -665.9% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| ROA | -42.0% | -54.3% | -42.4% | -39.8% | -41.9% | -32.8% | -37.7% | -66.5% | · | 158.5% | -16.4% | -50.9% | |
| ROE | -45.6% | -74.0% | -51.3% | -43.4% | -47.5% | -23.1% | -43.2% | -89.0% | · | 619.4% | -19.7% | -77.8% | |
| ROIC | -36.2% | · | · | -46.1% | · | -21.7% | -45.2% | -76.5% | · | -54.7% | -20.8% | -53.9% |
Likuiditas & Solvabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 | 19.2 | 10.0 | 8.7 | · | 1.1 | 7.9 | 7.5 | |
| Quick Ratio | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 | 18.0 | 9.5 | 7.4 | · | 1.1 | 7.1 | 7.4 | |
| Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | |
| LT Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -2740.8 | -10967.5 | -17134.7 | -5816.7 | -9565.5 | -144.2 | · | · | -62.3 | -48.4 |
Efisiensi 1
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.1 | 0.1 | 0.2 | · | 0.0 | · | · |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 105.0% | -95.3% | · | · | -46.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -83.5% | -62.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -65.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| Net Income TTM | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| Market Cap | $400M | $522M | $795M | $809M | $376M | $419M | $29M | $19M | · | · | · | · | |
| Enterprise Value | $161M | · | · | $629M | $187M | $205M | $-6M | $-15M | · | · | · | · | |
| P/E | -3.6 | -5.4 | -6.8 | -9.1 | -3.9 | -5.9 | 0.6 | 0.7 | 20.4 | · | · | · | |
| P/S | 9763.1 | 26083.1 | 1866.5 | -11902.0 | 85.1 | 51.2 | 5.0 | 1.8 | · | · | · | · | |
| P/B | 1.8 | 4.2 | 4.1 | 4.4 | 1.9 | 1.9 | 0.6 | 0.4 | · | · | · | · | |
| P / Tangible Book | 1.8 | 4.2 | 4.1 | 4.7 | 2.0 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -5.9 | -6.5 | -10.5 | -12.9 | -4.8 | -12.2 | -3.0 | -2.0 | · | · | · | · | |
| P / FCF | -5.9 | · | -10.5 | -12.9 | -4.2 | -12.1 | -3.0 | -1.8 | · | · | · | · | |
| EV / EBITDA | -1.7 | · | · | -7.2 | -1.9 | -3.8 | 0.3 | 0.3 | · | · | · | · | |
| EV / FCF | -2.4 | · | · | -10.0 | -2.1 | -5.9 | 0.7 | 1.4 | · | · | · | · | |
| EV / Revenue | 3929.7 | · | · | -9250.6 | 42.3 | 25.0 | -1.1 | -1.4 | · | · | · | · | |
| Earnings Yield | -27.7% | -18.6% | -14.8% | -11.0% | -25.7% | -16.9% | 154.5% | 141.8% | 4.9% | · | · | · |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $26.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $37.0K | $362.0K | $6.0K | $21.0K | $-110.0K | $2.0K | |
| R&D Expense | $19M | $16M | $18M | $15M | $17M | $16M | $20M | $20M | $21M | $21M | $17M | $18M | $13M | $17M | $19M | $20M | |
| SG&A Expense | $8M | $8M | $11M | $6M | $6M | $6M | $5M | $5M | $6M | $5M | $4M | $5M | $5M | $5M | $4M | $4M | |
| Operating Expenses | $26M | $24M | $29M | $21M | $23M | $22M | $25M | $25M | $27M | $27M | $34M | $23M | $18M | $22M | $23M | $25M | |
| Operating Income | $-26M | $-24M | $-29M | $-21M | $-23M | $-22M | $-25M | $-25M | $-27M | $-27M | $-34M | $-23M | $-18M | $-22M | $-23M | $-25M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1.0K | · | $29.0K | $2.0K | $2.0K | $-183.0K | $64.0K | |
| Interest Income | $5M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Other Non-op | $-25.0K | $-152.0K | $-27.0K | $-86.0K | $-92.0K | $15.0K | $118.0K | $18.0K | $-76.0K | $-12.0K | $20.0K | $14.0K | $113.0K | $19.0K | $-217.0K | $50.0K | |
| Pretax Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | · | · | $-22M | $-24M | |
| Income Tax | · | · | $0 | $0 | $0 | $-681.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $-197.0K | |
| Net Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | $-16M | $-20M | $-22M | $-24M | |
| EPS (Basic) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| EPS (Diluted) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| Shares (Basic) | 185,443,736 | 124,461,818 | -158,339,190 | 89,418,028 | 81,477,548 | 75,547,746 | -141,807,472 | 71,084,787 | 70,924,371 | 70,801,713 | -101,203,660 | 53,633,354 | 50,691,558 | 50,125,685 | -93,832,266 | 49,286,535 | |
| Shares (Diluted) | 185,443,736 | 124,461,818 | -158,339,190 | 89,418,028 | 81,477,548 | 75,547,746 | -141,807,472 | 71,084,787 | 70,924,371 | 70,801,713 | -101,203,660 | 53,633,354 | 50,691,558 | 50,125,685 | -93,832,266 | 49,286,535 | |
| EBITDA | $-26M | $-24M | · | $-21M | $-23M | $-22M | · | $-25M | $-27M | $-27M | · | $-23M | $-18M | $-22M | · | $-25M |
Neraca 24
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $98M | $44M | $61M | $183M | $49M | $37M | $31M | $57M | $79M | $135M | $87M | $102M | $105M | $111M | $127M | |
| Short-term Investments | $263M | $234M | $230M | $150M | · | $101M | $95M | $108M | $108M | $103M | $63M | $54M | $58M | $61M | $74M | $74M | |
| Prepaid Expense | $5M | $1M | $3M | $4M | $4M | $3M | $2M | $3M | $3M | $3M | $7M | $8M | $6M | $4M | $5M | $5M | |
| Current Assets | $335M | $335M | $278M | $217M | $188M | $155M | $137M | $146M | $171M | $188M | $210M | $153M | $170M | $173M | $193M | $211M | |
| PP&E (Net) | $60.0K | $208.0K | $312.0K | $337.0K | $364.0K | $384.0K | $413.0K | $446.0K | $483.0K | $544.0K | $651.0K | $765.0K | $882.0K | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $1M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | $12M | |
| Other Non-current Assets | $90.0K | $746.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $299.0K | $363.0K | $425.0K | $483.0K | $546.0K | $615.0K | $682.0K | |
| Total Assets | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Accounts Payable | $1M | $2M | $3M | $5M | $851.0K | $1M | $211.0K | $1M | $3M | $4M | $2M | $3M | $4M | $5M | $5M | $1M | |
| Current Liabilities | $13M | $11M | $15M | $13M | $9M | $10M | $10M | $9M | $15M | $11M | $12M | $12M | $11M | $15M | $17M | $16M | |
| Capital Leases | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $44.0K | $175.0K | $303.0K | $429.0K | $552.0K | $672.0K | $788.0K | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $5M | $16.0K | $5M | $26.0K | $31.0K | $37.0K | $40.0K | $46.0K | $52.0K | $56.0K | $60.0K | $66.0K | |
| Total Liabilities | $53M | $52M | $55M | $33M | $29M | $15M | $16M | $14M | $21M | $15M | $17M | $16M | $16M | $19M | $22M | $20M | |
| Long-term Debt | $35M | $35M | $34M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $35M | $35M | · | $14M | $14M | · | · | · | · | · | · | $4M | $4M | $4M | · | $5M | |
| Common Stock | $19.0K | $13.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $1.18B | $961M | $879M | $813M | $770M | $728M | $690M | $676M | $673M | $669M | $665M | $590M | $587M | $571M | $568M | $567M | |
| Retained Earnings | $-695M | $-672M | $-649M | $-622M | $-603M | $-581M | $-561M | $-538M | $-515M | $-491M | $-466M | $-435M | $-414M | $-398M | $-378M | $-356M | |
| AOCI | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Stockholders' Equity | $474M | $284M | $225M | $186M | $161M | $142M | $124M | $133M | $153M | $173M | $194M | $150M | $168M | $168M | $185M | $205M | |
| Liabilities + Equity | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Shares Outstanding | 194,474,154 | 130,221,154 | 110,882,735 | 95,598,665 | 85,076,300 | 77,825,450 | 72,352,701 | 71,124,407 | 71,046,267 | 70,899,134 | 70,677,400 | 52,858,920 | 52,657,661 | 49,286,710 | 49,199,845 | 49,161,637 |
Arus Kas 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $-552.0K | $-505.0K | $-356.0K | · | $-141.0K | |
| Stock-based Comp | $3M | $3M | $5M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $-681.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-24M | $-21M | $-19M | $-12M | $-19M | $-17M | $-18M | $-27M | $-18M | $-16M | $-17M | $-20M | $-19M | $-19M | $-17M | $-15M | |
| CapEx | $32.0K | $21.0K | $1.0K | $0 | · | · | · | · | · | · | $0 | $0 | $-4.0K | $51.0K | $38.0K | $60.0K | |
| Investing Cash Flow | $-221M | $-4M | $-79M | $-149M | $101M | $-5M | $14M | $1M | $-4M | $-40M | $-8M | $4M | $4M | $13M | $981.0K | $-25M | |
| Debt Issued | · | · | $20M | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $-89.0K | $9M | $62M | $40M | $38M | $35M | · | · | · | · | $73M | $510.0K | · | · | $0 | $32M | |
| Net Stock Activity | · | $9M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $211M | $78M | $81M | $39M | $52M | $34M | $10M | $266.0K | $-46.0K | $-261.0K | $73M | $588.0K | $13M | $-302.0K | $-43.0K | $32M | |
| Net Change in Cash | $-35M | $54M | $-17M | $-122M | $134M | $12M | $5M | $-26M | $-22M | $-56M | $48M | $-15M | $-2M | $-6M | $-16M | $-8M | |
| Free Cash Flow | · | $-21M | · | · | · | · | · | · | · | · | · | · | · | $-19M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -103614.3% | · | -1237600.0% | |
| Net Margin | · | · | · | -380280.0% | -442920.0% | -391500.0% | · | -456900.0% | -492800.0% | -487880.0% | · | -5710.2% | -267683.3% | -95590.5% | · | -1175800.0% | |
| Pretax Margin | · | · | · | -380280.0% | -442920.0% | -405120.0% | · | · | · | · | · | -5710.2% | · | · | · | -1185650.0% | |
| EBITDA Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -105309.5% | · | -1237600.0% | |
| ROA | -6.4% | -9.2% | · | -10.4% | -12.2% | -11.3% | · | -14.5% | -13.8% | -13.0% | · | -10.5% | -8.2% | -10.2% | · | -10.2% | |
| ROE | -7.2% | -10.6% | · | -11.9% | -14.1% | -12.4% | · | -16.1% | -15.4% | -14.3% | · | -11.6% | -8.9% | -11.4% | · | -11.3% | |
| ROIC | · | · | · | · | · | -14.8% | · | · | · | · | · | · | · | · | · | -11.7% |
Likuiditas & Solvabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.8 | 29.6 | · | 17.2 | 20.4 | 15.8 | · | 16.9 | 11.3 | 16.5 | · | 12.9 | 14.8 | 11.6 | · | 13.4 | |
| Quick Ratio | 26.1 | 29.3 | · | 16.7 | 19.9 | 15.3 | · | 16.1 | 10.9 | 16.1 | · | 11.9 | 14.0 | 11.1 | · | 12.8 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -26794.0 | · | -777.2 | -9003.5 | -10879.5 | · | -386.8 |
Efisiensi 1
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valuasi (TTM) 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.0K | $20.0K | · | $20.0K | $20.0K | $20.0K | · | $377.0K | $378.0K | $394.0K | · | $391.0K | $37.0K | $63.0K | · | $200.0K | |
| Net Income TTM | $-87M | $-83M | · | $-84M | $-89M | $-91M | · | $-93M | $-86M | $-81M | · | $-80M | $-80M | $-83M | · | $-97M | |
| Market Cap | $591M | $401M | · | $360M | $329M | $389M | · | $437M | $472M | $722M | · | $137M | $186M | $208M | · | $628M | |
| Enterprise Value | $300M | $104M | · | $164M | $160M | · | · | · | · | · | · | $959.2K | $30M | $47M | · | $430M | |
| P/E | -3.9 | -3.3 | · | -3.6 | -3.2 | -3.9 | · | -4.4 | -4.8 | -7.0 | · | -1.6 | -2.2 | -2.4 | · | -5.9 | |
| P/S | 29560.1 | 20054.1 | · | 18020.3 | 16462.3 | 19456.4 | · | 1158.4 | 1249.9 | 1831.9 | · | 351.5 | 5023.8 | 3301.4 | · | 3139.0 | |
| P/B | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.1 | |
| P / Tangible Book | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.3 | |
| P / Cash Flow | · | -19.2 | · | · | · | -23.1 | · | · | · | -44.1 | · | · | · | -10.7 | · | · | |
| P / FCF | · | -19.1 | · | · | · | · | · | · | · | · | · | · | · | -10.7 | · | · | |
| EV / EBITDA | -11.4 | -4.3 | · | -7.9 | -7.0 | · | · | · | · | · | · | -0.0 | -1.7 | -2.1 | · | -17.4 | |
| EV / FCF | · | -5.0 | · | · | · | · | · | · | · | · | · | · | · | -2.4 | · | · | |
| EV / Revenue | 14983.1 | 5202.3 | · | 8203.8 | 8023.6 | · | · | · | · | · | · | 2.5 | 813.3 | 740.6 | · | 2152.4 | |
| Earnings Yield | -25.7% | -29.9% | · | -28.1% | -31.0% | -25.4% | · | -22.8% | -21.1% | -14.2% | · | -61.2% | -45.9% | -41.2% | · | -16.8% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $41.0K | $20.0K | $426.0K | $-68.0K | $4M |
| Margin Operasi % | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% |
| Laba Bersih | $-88M | $-95M | $-88M | $-85M | $-97M |
| EPS Dilusian | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.2 | — | — | 0.0 | 0.0 |
| Rasio Lancar | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 |
| Rasio Cepat | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-68M | — | $-76M | $-63M | $-90M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 238 pengaju · $355.5M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 61 (+31 vs Kuartal sebelumnya) | 17 (-16 vs Kuartal sebelumnya) | 82 (0 vs Kuartal sebelumnya) | 38 (-2 vs Kuartal sebelumnya) | +67.7M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Deep Track Capital, LP | $58.520.000 | 19.250.000 | 16,46% | Saham |
| STATE STREET CORP | $36.779.562 | 12.098.540 | 10,35% | Saham |
| TCG Crossover Management, LLC | $30.400.000 | 10.000.000 | 8,55% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.860.366 | 8.177.752 | 6,99% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22.284.006 | 7.330.265 | 6,27% | Saham |
| VIKING GLOBAL INVESTORS LP | $20.368.000 | 6.700.000 | 5,73% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $19.760.000 | 6.500.000 | 5,56% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $13.042.903 | 4.289.189 | 3,67% | Saham |
| Woodline Partners LP | $10.336.948 | 3.400.312 | 2,91% | Saham |
| MILLENNIUM MANAGEMENT LLC | $10.059.731 | 3.309.122 | 2,83% | Saham |
| Trails Edge Capital Partners, LP | $8.086.400 | 2.660.000 | 2,27% | Saham |
| TWO SIGMA INVESTMENTS, LP | $7.238.672 | 2.381.142 | 2,04% | Saham |
| GOLDMAN SACHS GROUP INC | $5.713.595 | 1.879.472 | 1,61% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.469.872 | 1.799.300 | 1,54% | Opsi beli |
| GREAT POINT PARTNERS LLC | $5.293.345 | 1.741.232 | 1,49% | Saham |
| Weiss Asset Management LP | $4.653.641 | 1.530.803 | 1,31% | Saham |
| Nantahala Capital Management, LLC | $4.560.000 | 1.500.000 | 1,28% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $3.930.723 | 1.293.001 | 1,11% | Saham |
| Cormorant Asset Management, LP | $3.800.000 | 1.250.000 | 1,07% | Saham |
| TWO SIGMA ADVISERS, LP | $2.865.979 | 793.900 | 0,81% | Saham |
| VANGUARD GROUP INC | $2.531.996 | 701.384 | 0,71% | Saham |
| MARSHALL WACE, LLP | $2.424.799 | 797.631 | 0,68% | Saham |
| Ghisallo Capital Management LLC | $2.280.000 | 750.000 | 0,64% | Saham |
| FMR LLC | $2.276.297 | 748.782 | 0,64% | Saham |
| BlackRock, Inc. | $2.190.606 | 720.594 | 0,62% | Saham |
| TANG CAPITAL MANAGEMENT LLC | $2.024.707 | 666.022 | 0,57% | Saham |
| CITADEL ADVISORS LLC | $1.918.240 | 631.000 | 0,54% | Opsi beli |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.898.477 | 624.499 | 0,53% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $1.789.581 | 588.678 | 0,50% | Saham |
| BANK OF AMERICA CORP /DE/ | $1.711.815 | 563.097 | 0,48% | Saham |
| Point72 Asset Management, L.P. | $1.480.127 | 486.884 | 0,42% | Saham |
| Rock Springs Capital Management LP | $1.433.254 | 471.465 | 0,40% | Saham |
| Beirne Wealth Consulting Services, LLC | $1.282.449 | 421.858 | 0,36% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $1.128.375 | 371.176 | 0,32% | Saham |
| BARCLAYS PLC | $1.021.313 | 335.958 | 0,29% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $990.128 | 325.700 | 0,28% | Opsi jual |
| RHUMBLINE ADVISERS | $941.193 | 309.606 | 0,26% | Saham |
| LMR Partners LLP | $912.000 | 300.000 | 0,26% | Saham |
| CITIGROUP INC | $857.496 | 282.071 | 0,24% | Saham |
| Steward Partners Investment Advisory, LLC | $810.680 | 266.671 | 0,23% | Saham |
| MANGROVE PARTNERS IM, LLC | $727.411 | 239.280 | 0,20% | Saham |
| Baird Financial Group, Inc. | $722.067 | 237.522 | 0,20% | Saham |
| BROWN WEALTH MANAGEMENT, LLC | $717.853 | 236.136 | 0,20% | Saham |
| JANE STREET GROUP, LLC | $691.296 | 227.400 | 0,19% | Opsi beli |
| Rafferty Asset Management, LLC | $684.182 | 225.060 | 0,19% | Saham |
| COMMONWEALTH EQUITY SERVICES, LLC | $652.300 | 214.574 | 0,18% | Saham |
| WOLVERINE TRADING, LLC | $637.478 | 168.200 | 0,18% | Opsi beli |
| Squarepoint Ops LLC | $615.235 | 202.380 | 0,17% | Saham |
| ALPS ADVISORS INC | $600.017 | 197.374 | 0,17% | Saham |
| STIFEL FINANCIAL CORP | $584.799 | 192.368 | 0,16% | Saham |
| Jump Financial, LLC | $577.600 | 190.000 | 0,16% | Saham |
| Man Group plc | $528.571 | 173.872 | 0,15% | Saham |
| WELLS FARGO & COMPANY/MN | $506.063 | 166.468 | 0,14% | Saham |
| Knoll Capital Management, LLC | $486.400 | 160.000 | 0,14% | Saham |
| Birchview Capital, LP | $464.150 | 152.681 | 0,13% | Saham |
| ALLIANCEBERNSTEIN L.P. | $433.818 | 140.850 | 0,12% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $407.053 | 133.899 | 0,11% | Saham |
| Brevan Howard Capital Management LP | $397.574 | 130.781 | 0,11% | Saham |
| XTX Topco Ltd | $389.388 | 128.088 | 0,11% | Saham |
| CITADEL ADVISORS LLC | $389.120 | 128.000 | 0,11% | Opsi jual |
| Virtus Investment Advisers, LLC | $381.104 | 125.363 | 0,11% | Saham |
| WEALTH EFFECTS LLC | $372.856 | 122.650 | 0,10% | Saham |
| LPL Financial LLC | $370.734 | 121.952 | 0,10% | Saham |
| MetLife Investment Management, LLC | $355.242 | 116.856 | 0,10% | Saham |
| PROFUND ADVISORS LLC | $345.338 | 113.598 | 0,10% | Saham |
| D. E. Shaw & Co., Inc. | $340.285 | 111.936 | 0,10% | Saham |
| Jefferies Financial Group Inc. | $334.400 | 110.000 | 0,09% | Saham |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $314.640 | 103.500 | 0,09% | Saham |
| Susquehanna Portfolio Strategies, LLC | $314.257 | 103.374 | 0,09% | Saham |
| Summit Financial Wealth Advisors, LLC | $313.996 | 103.288 | 0,09% | Saham |
| ADAR1 Capital Management, LLC | $312.582 | 102.823 | 0,09% | Saham |
| Mariner, LLC | $307.407 | 101.123 | 0,09% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $304.000 | 100.000 | 0,09% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $278.276 | 91.538 | 0,08% | Saham |
| CANADA PENSION PLAN INVESTMENT BOARD | $265.392 | 87.300 | 0,07% | Saham |
| Grantham, Mayo, Van Otterloo & Co. LLC | $254.864 | 83.837 | 0,07% | Saham |
| Invesco Ltd. | $241.625 | 79.482 | 0,07% | Saham |
| Vanguard Global Advisers, LLC | $228.137 | 75.045 | 0,06% | Saham |
| KINGSWOOD WEALTH ADVISORS, LLC | $226.480 | 74.500 | 0,06% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $217.664 | 71.600 | 0,06% | Saham |
| Bank of New York Mellon Corp | $206.136 | 67.808 | 0,06% | Saham |
| IEQ CAPITAL, LLC | $203.540 | 66.954 | 0,06% | Saham |
| PVG ASSET MANAGEMENT CORP | $201.005 | 66.120 | 0,06% | Saham |
| HSBC HOLDINGS PLC | $199.504 | 64.460 | 0,06% | Saham |
| Leonteq Securities AG | $194.560 | 64.000 | 0,05% | Saham |
| Police & Firemen's Retirement System of New Jersey | $178.220 | 58.625 | 0,05% | Saham |
| AXQ CAPITAL, LP | $172.702 | 56.810 | 0,05% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $172.499 | 56.743 | 0,05% | Saham |
| WOLVERINE TRADING, LLC | $163.728 | 43.200 | 0,05% | Opsi jual |
| MERCER GLOBAL ADVISORS INC /ADV | $161.470 | 53.115 | 0,05% | Saham |
| Corient Private Wealth LP | $161.219 | 53.032 | 0,05% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $160.351 | 52.747 | 0,05% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $158.189 | 52.036 | 0,04% | Saham |
| Cetera Investment Advisers | $157.779 | 51.901 | 0,04% | Saham |
| JANE STREET GROUP, LLC | $150.176 | 49.400 | 0,04% | Opsi jual |
| Caption Management, LLC | $141.716 | 46.617 | 0,04% | Saham |
| INTECH INVESTMENT MANAGEMENT LLC | $139.569 | 45.911 | 0,04% | Saham |
| Quantbot Technologies LP | $138.721 | 45.632 | 0,04% | Saham |
| Graham Capital Management, L.P. | $136.618 | 44.940 | 0,04% | Saham |
| AMERIPRISE FINANCIAL INC | $135.639 | 44.618 | 0,04% | Saham |
Orang dalam perusahaan 48 orang dalam · 25 pejabat · 20 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Vipin K Garg | President and CEO | 2 Feb. 2025 M | 355.082 | 0 | 0 | $0 |
| William Enright | President and CEO | 25 Mei 2018 P | 365.839 | 0 | 0 | $0 |
| David P Wright | President and CEO | 11 Des. 2009 P | 399.500 | 0 | 0 | $0 |
| Gregory L Weaver | Chief Financial Officer | 31 Juli 2026 A | 39.831 | 2 | 0 | $49.200 |
| Andrew Shutterly | Acting Chief Financial Officer | 31 Juli 2024 A | 11.372 | 0 | 0 | $0 |
| Richard I Eisenstadt | Chief Financial Officer | 30 Jan. 2024 M | 45.012 | 0 | 0 | $0 |
| William Michael Brown | Chief Financial Officer | 31 Juli 2021 A | 17.721 | 0 | 0 | $0 |
| Elizabeth Czerepak | CFO and EVP Corp. Development | 22 Sep. 2017 A | — | 0 | 0 | $0 |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | 21 Des. 2016 M | 126.346 | 0 | 0 | $0 |
| Linda L Chang | SVP, CFO & Secretary | 7 Jan. 2015 M | 30.000 | 0 | 0 | $0 |
| Charles A. Reinhart III | SVP, Chief Financial Officer | 8 Des. 2010 A | — | 0 | 0 | $0 |
| Kevin Price | President - PharmAthene UK,Ltd | 21 Jan. 2009 A | 2.500 | 0 | 0 | $0 |
| Jeffrey Michael Jones | COO | 11 Maret 2015 A | 27.544 | 0 | 0 | $0 |
| Scot M Roberts | Chief Scientific Officer | 31 Juli 2026 A | 113.699 | 0 | 0 | $0 |
| Christophe Arbet-Engels | Chief Medical Officer | 1 Okt. 2025 A | — | 0 | 0 | $0 |
| Linda M Richardson | Chief Commercial Officer | 16 Sep. 2025 A | — | 0 | 0 | $0 |
| Raymond M Jordt | Chief Business Officer | 31 Juli 2025 A | 36.270 | 0 | 0 | $0 |
| Matthew Scott Harris | Chief Medical Officer | 31 Juli 2025 A | 16.087 | 0 | 0 | $0 |
| Sybil Tasker | Chief Medical Officer | 17 Juni 2019 A | — | 0 | 0 | $0 |
| Wayne Morges | SVP, Reg. Affairs & Quality | 8 Des. 2014 A | 35.532 | 0 | 0 | $0 |
| Francesca M Cook | SVP, Policy & Gov't Affairs | 8 Des. 2014 A | 37.631 | 0 | 0 | $0 |
| Thomas Richard Fuerst | EVP, Chief Scientific Officer | 1 Des. 2011 A | 15.000 | 0 | 0 | $0 |
| Valerie D Riddle | SVP, Medical Director | 31 Mei 2011 M | 44.436 | 0 | 0 | $0 |
| Joan Fusco | SVP, Operations | 6 Mei 2010 A | 36.730 | 0 | 0 | $0 |
| Christopher C Camut | VP, Gov't Contracts | 21 Jan. 2010 F | 46.777 | 0 | 0 | $0 |
| John Gill | Direktur | 1 Mei 2026 A | 21.700 | 2 | 0 | $82.622 |
| Mitchel Sayare | Direktur | 1 Mei 2026 A | 26.363 | 0 | 0 | $0 |
| Teri L Lawver | Direktur | 25 Sep. 2025 A | — | 0 | 0 | $0 |
| Wayne Pisano | Direktur | 25 Sep. 2025 A | 8.498 | 0 | 0 | $0 |
| Klaus Schafer | Direktur | 25 Sep. 2025 A | 9.179 | 0 | 0 | $0 |
| Philip Hodges | Direktur | 25 Sep. 2025 A | 8.731 | 0 | 0 | $0 |
| Catherine A. Sohn | Direktur | 25 Sep. 2025 A | 1.000 | 0 | 0 | $0 |
| Diane Jorkasky | Direktur | 25 Sep. 2025 A | 0 | 0 | 0 | $0 |
| David Drutz | Direktur | 19 Agu 2024 M | 55.524 | 0 | 0 | $0 |
| SCHAFFER DERACE L | Direktur | 29 Des. 2017 P | 589.453 | 0 | 0 | $0 |
| Jeffrey W. Runge | Direktur | 20 Jan. 2017 M | 197.700 | 0 | 0 | $0 |
| Steven St Peter | Direktur | 4 Jan. 2017 M | 205.004 | 0 | 0 | $0 |
| Eric I Richman | Direktur | 22 Nov. 2016 M | 898.055 | 0 | 0 | $0 |
| Joel Mccleary | Direktur | 31 Des. 2014 A | 120.167 | 0 | 0 | $0 |
| Brian A Markison | Direktur | 31 Des. 2014 A | — | 0 | 0 | $0 |
| John Pappajohn | Direktur | 23 Juni 2011 A | 394.044 | 0 | 0 | $0 |
| CAVANAUGH JAMES H | Direktur | 23 Juni 2010 A | — | 0 | 0 | $0 |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | Pemilik 10% | 15 Mei 2020 S | 1.687.250 | 0 | 0 | $0 |
| Truffle Capital S.A.S. | Pemilik 10% | 13 Feb. 2018 J | 76.700 | 0 | 0 | $0 |
| ANSBERT GADICKE | Pemilik 10% | 3 Agu 2007 A | — | 0 | 0 | $0 |
| Jerome Benedict Durso | — | 13 Agu 2026 P | 62.500 | 1 | 0 | $44.250 |
| Jordan P Karp | — | 3 Des. 2012 A | 21.929 | 0 | 0 | $0 |
| Matthew P Kinley | — | 3 Agu 2007 P | 541.000 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 18 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Shah, Nimish, Koh, Bong | 25 Juni 2020 | — | Pengajuan awal | Investasi pasif | SEC |
| Philip Hodges, Redmont Venture Partners, Inc., Redmont VAXN Capital Holdings, LLC, Paradigm Venture Partners, L.P. ×3 pengajuan | 19 Okt. 2017 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 30 Maret 2016 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 12 Feb. 2016 | — | Pengajuan awal | — | SEC |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., PRESCOTT GROUP AGGRESSIVE SMALL CAP, L.P., PRESCOTT GROUP AGGRESSIVE SMALL CAP II, L.P., PHIL FROHLICH ×6 pengajuan | 2 Des. 2013 | — | Pengajuan awal | Investasi pasif | SEC |
| Theraclone Sciences, Inc. | 12 Agu 2013 | — | Pengajuan awal | M&A / penjualan | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 27 Des. 2010 | — | Pengajuan awal | Investasi pasif | SEC |
| Kelisia Holdings L imited, Panacea Biotec Limited | 18 Sep. 2009 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 4 Agu 2009 | — | Pengajuan awal | Investasi pasif | SEC |
| HealthCare Ventures VII, L.P., HealthCare Partners VII, L.P., James H. Cavanaugh, Ph.D., John Littlechild, Harold Werner, Augustine Lawlor, Christopher Mirabelli, Ph.D. ×3 pengajuan | 3 Agu 2009 | — | Pengajuan awal | Investasi pasif | SEC |
| Bear Stearns Health Innoventures, L.P., Bear Stearns Health Innoventures Offshore, L.P., BX, L.P., Bear Stearns Health Innoventures Employee Fund, L.P., BSHI Members, L.L.C., Bear Stearns Health Innoventures Management, L.L.C., Bear Stearns Asset Management Inc. ×3 pengajuan | 29 Mei 2009 | — | Pengajuan awal | Kampanye dewan | SEC |
| Integrated Core Strategies (US) LLC, Riverview Group LLC, Millennium Management LLC, Israel A. Englander ×2 pengajuan | 23 April 2009 | — | Pengajuan awal | M&A / penjualan | SEC |
| Nexia Biotechnologies Ltd. | 30 Mei 2008 | — | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 17 Agu 2007 | — | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 14 Agu 2007 | — | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 33 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,48% | 36.663 SH | 21 Agu 2026 | Harian |
| BBC · ETFis Series Trust I | 0,36% | 52.374 NS | 30 April 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,25% | 134.076 NS | 31 Mei 2026 | N-PORT |
| IWC · iShares Trust | 0,13% | 687.093 SH | 21 Agu 2026 | Harian |
| LABU · Direxion Shares ETF Trust | 0,12% | 248.923 NS | 30 April 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 172.834 SH | 19 Agu 2026 | Harian |
| IBB · iShares Trust | 0,04% | 1.363.463 SH | 21 Agu 2026 | Harian |
| IWN · iShares Trust | 0,04% | 1.856.868 SH | 21 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 11.441 SH | 21 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1.142.675 SH | 19 Agu 2026 | Harian |
| BIB · ProShares Trust | 0,02% | 4.631 NS | 31 Mei 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 183.437 SH | 21 Agu 2026 | Harian |
| IWM · iShares Trust | 0,02% | 5.082.460 SH | 21 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 56.560 NS | 30 April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.235.429 SH | 19 Agu 2026 | Harian |
| ITWO · ProShares Trust | 0,01% | 6.144 NS | 31 Mei 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 569.267 SH | 19 Agu 2026 | Harian |
| RB · ProShares Trust | 0,01% | 38 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 414.821 NS | 30 April 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 4.804 NS | 31 Mei 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 4.861 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 122 NS | 31 Mei 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 359.624 SH | 21 Agu 2026 | Harian |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.514 NS | 31 Mei 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 8.167 NS | 30 April 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 763 NS | 31 Mei 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 23.337 SH | 21 Agu 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 25.408 NS | 30 April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9.653 NS | 30 April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 34.439 NS | 30 April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.748.771 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 16.865 SH | 19 Agu 2026 | Harian |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 353 NS | 31 Mei 2026 | N-PORT |